Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Rhinoscintigraphy

Daniela Di GiudaNuclear Medicine Institute, Catholic University of the Sacred Heart, Rome, ItalyJacopo Gallithe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, ItalyMaria Lucia Calcagnithe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, ItalyLuigi Corinathe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, ItalyGaetano Paludettithe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, ItalyFabrizio Ottavianithe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, ItalyGiuseppe Rossithe Nuclear Medicine Institute* and Clinics of Otorhinolaryngology,† Catholic University of the Sacred Heart, Rome, Italy
2000en
ABI

Аннотация

PURPOSE: This was a radioisotope study of nasal mucociliary clearance of total and subtotal nasal obstruction. METHODS: Rhinoscintigraphy was performed by insufflating 1.85 MBq (69 mCi) Tc-99m MAA in 20 patients. Six cases were regarded as the control group, because the presence of small spurs does not affect nasal patency. The remaining 14 patients had various rhinopathic conditions. Two regions of interest were selected, one in the nasal cavity and one in the pharynx. Mucociliary transport speed was calculated. RESULTS: This parameter appeared to be a sensitive index for the assessment of the degree of mucociliary alteration. It showed that polyposis impairs mucociliary transport most severely, thus confirming the results of other published studies. CONCLUSIONS: Rhinoscintigraphy proved to be a reliable, easily reproducible, and harmless method, so it may be used for follow-up examinations in patients who have had surgery of the nose and paranasal sinuses, and for drug therapy of rhinopathic conditions.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0